Xenetic Biosciences Inc.

07/07/2022 | Press release | Distributed by Public on 07/07/2022 07:07

Xenetic Biosciences, Inc. Engages Catalent for Clinical Manufacturing to Advance DNase-Based Oncology Platform Towards Phase 1 Study